EA202092189A1 - Фармацевтический комбинированный препарат, содержащий эзетимиб и розувастатин - Google Patents
Фармацевтический комбинированный препарат, содержащий эзетимиб и розувастатинInfo
- Publication number
- EA202092189A1 EA202092189A1 EA202092189A EA202092189A EA202092189A1 EA 202092189 A1 EA202092189 A1 EA 202092189A1 EA 202092189 A EA202092189 A EA 202092189A EA 202092189 A EA202092189 A EA 202092189A EA 202092189 A1 EA202092189 A1 EA 202092189A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- rosuvastatin
- preparation containing
- ezetimib
- combined preparation
- pharmaceutical combined
- Prior art date
Links
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 title abstract 3
- 229960000815 ezetimibe Drugs 0.000 title abstract 3
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title abstract 3
- 229960000672 rosuvastatin Drugs 0.000 title abstract 3
- 239000002083 C09CA01 - Losartan Substances 0.000 abstract 2
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 abstract 2
- 229960000528 amlodipine Drugs 0.000 abstract 2
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 abstract 2
- 229960004773 losartan Drugs 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180031536A KR102569271B1 (ko) | 2018-03-19 | 2018-03-19 | 에제티미브 및 로수바스타틴을 포함하는 약제학적 복합제제 |
| PCT/KR2019/002769 WO2019182276A1 (fr) | 2018-03-19 | 2019-03-11 | Préparation d'une association de produits pharmaceutiques comprenant de l'ézétimibe et de la rosuvastatine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202092189A1 true EA202092189A1 (ru) | 2020-12-14 |
Family
ID=67986281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202092189A EA202092189A1 (ru) | 2018-03-19 | 2019-03-11 | Фармацевтический комбинированный препарат, содержащий эзетимиб и розувастатин |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR102569271B1 (fr) |
| CN (1) | CN111886003A (fr) |
| CO (1) | CO2020010204A2 (fr) |
| EA (1) | EA202092189A1 (fr) |
| MX (1) | MX2020009492A (fr) |
| PH (1) | PH12020500656A1 (fr) |
| SG (1) | SG11202007869WA (fr) |
| TW (1) | TW201944992A (fr) |
| WO (1) | WO2019182276A1 (fr) |
| ZA (1) | ZA202004982B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102500643B1 (ko) * | 2019-04-18 | 2023-02-16 | 한미약품 주식회사 | 에제티미브 및 로사르탄을 포함하는 약제학적 복합제제 |
| WO2021226561A1 (fr) * | 2020-05-07 | 2021-11-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Agents thérapeutiques contre la covid-19 et méthodes de traitement de la covid-19 |
| BR112023003323A2 (pt) * | 2020-08-25 | 2023-03-21 | Daewoong Pharmaceutical Co Ltd | Composição farmacêutica em forma de dosagem única |
| GB2622822A (en) * | 2022-09-28 | 2024-04-03 | Novumgen Ltd | A rapidly disintegrating tablet of rosuvastatin and its process of preparation |
| KR20250161310A (ko) | 2024-05-08 | 2025-11-17 | 한미약품 주식회사 | 복약순응도가 개선된 에제티미브, 로수바스타틴 및 엠파글리플로진을 포함하는 복합제제 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009024889A2 (fr) * | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Composition pharmaceutique comprenant un inhibiteur de réductase hmg-coa et un ézétimibe |
| ES2802252T3 (es) * | 2012-05-01 | 2021-01-18 | Althera Life Sciences Llc | Formulación de comprimido oral que consiste en la combinación fija de rosuvastatina y ezetimiba para el tratamiento de hiperlipidemia y enfermedades cardiovasculares |
| CN103585157B (zh) * | 2013-11-13 | 2016-02-03 | 武汉武药科技有限公司 | 一种含依折麦布和瑞舒伐他汀的双层片及其制备方法 |
| KR101910901B1 (ko) * | 2013-11-29 | 2018-10-24 | 한미약품 주식회사 | 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제 |
| KR20150079373A (ko) * | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| EP3243506A1 (fr) * | 2016-05-09 | 2017-11-15 | Adamed sp. z o.o. | Composition pharmaceutique |
-
2018
- 2018-03-19 KR KR1020180031536A patent/KR102569271B1/ko active Active
-
2019
- 2019-03-11 CN CN201980020077.6A patent/CN111886003A/zh active Pending
- 2019-03-11 SG SG11202007869WA patent/SG11202007869WA/en unknown
- 2019-03-11 EA EA202092189A patent/EA202092189A1/ru unknown
- 2019-03-11 MX MX2020009492A patent/MX2020009492A/es unknown
- 2019-03-11 WO PCT/KR2019/002769 patent/WO2019182276A1/fr not_active Ceased
- 2019-03-14 TW TW108108673A patent/TW201944992A/zh unknown
-
2020
- 2020-08-12 ZA ZA2020/04982A patent/ZA202004982B/en unknown
- 2020-08-19 CO CONC2020/0010204A patent/CO2020010204A2/es unknown
- 2020-08-27 PH PH12020500656A patent/PH12020500656A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202004982B (en) | 2023-02-22 |
| KR20190109892A (ko) | 2019-09-27 |
| MX2020009492A (es) | 2021-01-15 |
| KR102569271B1 (ko) | 2023-08-23 |
| CO2020010204A2 (es) | 2020-08-31 |
| TW201944992A (zh) | 2019-12-01 |
| PH12020500656A1 (en) | 2021-06-21 |
| WO2019182276A1 (fr) | 2019-09-26 |
| CN111886003A (zh) | 2020-11-03 |
| SG11202007869WA (en) | 2020-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202092189A1 (ru) | Фармацевтический комбинированный препарат, содержащий эзетимиб и розувастатин | |
| EA202092580A1 (ru) | Соединения, ингибирующие rip1, а также способы их получения и применения | |
| MX381787B (es) | Derivados de piridiniltriazol sustituidos con amida y usos de estos. | |
| EA202092896A1 (ru) | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона | |
| MX2020013853A (es) | Compuestos innovadores. | |
| MX389697B (es) | Nuevos derivados de pirazolopirimidina. | |
| MX375779B (es) | Derivados de feniltriazol sustituido con hidroxialquilo y sus usos. | |
| EA201792047A1 (ru) | Новые соединения | |
| EA202090448A1 (ru) | Дигидрооксадиазиноны | |
| EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
| PH12019502365A1 (en) | New bicyclic pyrazole derivatives | |
| EA202091256A1 (ru) | Новые антагонисты рецептора брадикинина | |
| MX2021004331A (es) | Composiciones estables de semaglutida y usos de las mismas. | |
| EP4327880A3 (fr) | Forme à l'état solide de succinate de ribociclib | |
| WO2017136731A8 (fr) | Rapaglutines : nouveaux inhibiteurs de glut, et leur utilisation | |
| EA201891608A1 (ru) | Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана | |
| EA201891611A1 (ru) | Роизводные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диазаспиро[4,5]декана | |
| HK1257296A1 (zh) | 新的化合物及其用途 | |
| TN2018000372A1 (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions. | |
| EA201891612A1 (ru) | Производные 3-(карбоксиметил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана | |
| EA201692289A1 (ru) | Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов | |
| EA201990158A1 (ru) | Производные бензодиоксана и их фармацевтическое применение | |
| MX2020008929A (es) | Compuestos de dihidropirimidinona o dihidrotriazinona fusionados con anillos saturados y su uso farmaceutico. | |
| EA201992509A1 (ru) | Гетероарилфениламинохинолины и аналоги | |
| EA201990526A1 (ru) | Конъюгат миноксидила и пептида |